Scientific Online Resource System

Scripta Scientifica Medica

BLADDER CANCER IMMUNOTHERAPY

A. Hinev, D. Gochev, A. Engibarov, V. Ajladunov, L. Ralichkova, K. Kisyova, M. Chuchkova

Abstract

No abstract

Keywords

Bladder cancer; immunotherapy; BCG CALGEVAX; prophylaxis; side effects

Full Text


References

Дамянов, X., А. Енгибаров, Т. Патрашков, Т. Тончев, М. Чучковал Хирургия, 1988, № 2, 23-28.

Куманов, Х., С. Тачев.- В: Тумори на урогениталната система у мъжа. София, ЦНИМЗ, 1984, 39-48.

Boehle, A. et al.- In: Immunotherapy of Urogenital Tumours. Edinburgh, etc., Churchill-Livingstone, 1990, 83-106.

Engibarov, A,, M. Chouchkova, R. Ikonopisov. Develop. Biol. Standard, 58, 1986, 365-369.

DeBruyne, F., A. Van der Meijden, A. Geboers. Urology (Suppl.), 31, 1988, p. 20.

DeKernion, J. et al. J. Urol., 133, 1985, 598-601.

Kelley, D. et аl. J. Urol., 134, 1985, 48-53.

Lamm, D. et al. J. Urol., 128, 1982, 931-935.

Morales, A., D. Eidinger, A Bruce. J. Urol., 116, 1976, 180-183.

Morales, A. J. Urol., 132, 1984, 457-459.

Nissenkorn, I. et al. Europ. Urol., 13, 1987, 246.

Robinson, M. et al.- In: Bladder Tumours and Other Topics in Urological Oncology. New York, Plenum Press, 1980, p. 171.




DOI: http://dx.doi.org/10.14748/ssm.v27i0.3730

Refbacks

Article Tools
Email this article (Login required)
About The Authors

A. Hinev

D. Gochev

A. Engibarov

V. Ajladunov

L. Ralichkova

K. Kisyova

M. Chuchkova

Font Size


|